Sun Pharmaceutical Industries Ltd is buying US-based immunotherapy and oncology firm Checkpoint Therapeutics Inc. for $355 million. A bird flies past the logo of Sun Pharma installed on the facade ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...